Navigation Links
St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
Date:11/21/2007

The discovery of a new cytokine called IL-35 could allow clinicians to treat diseases by turning up or down the immune response

MEMPHIS, Tenn., Nov. 21 /PRNewswire-USNewswire/ -- Investigators at St. Jude Children's Research Hospital have discovered a new signaling molecule that prevents immune responses from running amok and damaging the body. The finding could lead to the development of new treatments for cancer, using vaccines; for autoimmune diseases, such as Type 1 diabetes; and for inflammatory diseases, such as inflammatory bowel disease and asthma.

The St. Jude team discovered that specialized immune lymphocytes called regulatory T cells release a protein complex composed of two proteins called Ebi3 and Il12a. This complex acts like a brake on the activity of the aggressive immune cells called effector T lymphocytes. The discovery is important because the manipulation of regulatory T cells is a key goal of immunotherapy. A report on this discovery appears in the journal "Nature" Nov. 22, 2007.

The newly recognized protein complex is one of a large group of signaling molecules called cytokines that cells use to communicate with each other. Since the immune system cytokines are called interleukins, the St. Jude team named this protein interleukin-35 (IL-35). Most cytokines stimulate immune system cells; however, IL-35 is one of the few signaling molecules known to inhibit immune system activity.

"The maximal suppressive function of regulatory T cells depends on IL-35, so blocking IL-35 activity might reduce the ability of T cells to block anti-tumor immune responses," said Dario Vignali, Ph.D., associate member in the St. Jude Department of Immunology, and the paper's senior author. "Treatments that block IL-35 activity may make anti-cancer vaccines more effective and provide new therapeutic opportunities for autoimmune and inflammatory diseases."

"Our findings suggest that controlling levels of IL-35 in pati
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
2. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
3. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
4. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
5. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
6. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
8. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
9. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
10. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
11. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SANTA CLARA, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced the introduction of the cQUB™-1 (cQuest Ultrasound ... cQUB white-label ultrasound systems designed and manufactured by Cephasonics ... brand name and model number. Cephasonics will be showcasing ... 2014 being held this week in Chongqing, ...
(Date:10/22/2014)... -- Investor-Edge has initiated coverage on the ... ), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), ... Pharmaceuticals Inc. (NASDAQ: IDRA ), and Merrimack ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,419.48, up 2.40%, the Dow Jones Industrial ...
(Date:10/22/2014)... N.J. , Oct. 22, 2014   ... a world-renowned leader in the field of infertility, ... approach to embryonic screening. The research abstract, released ... for Reproductive Medicine (ASRM) meeting in ... (CCS) and single gene defect (SGD) pre-implantation genetic ...
Breaking Medicine Technology:Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
... 2011  Radient Pharmaceuticals Corporation  (OTCQX:RXPC) (OTCPK:RXPC), developer and ... (IVD) cancer test, today announced it has ... Noteholders (who hold convertible notes and shares of ... Anstalt ("Alpha") and Whalehaven Capital Fund Ltd. ("Whalehaven").  ...
... 29, 2011 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), through ... announces it active participation at " HOW TO BECOME A GLOBAL ... for Chinese Companies Going Global " ... Corporation and Loeb & Loeb LLP, a seminar held in Shanghai, ...
Cached Medicine Technology:Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital 2Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital 3China Health Resource Goes Global 2China Health Resource Goes Global 3
(Date:10/22/2014)... RESTON, Va. (PRWEB) October 22, 2014 ... Healthcare Innovation , which is dedicated to distribute ... efficiency of healthcare delivery worldwide announced the development ... in which patients expect when receiving healthcare. These ... definition for patient-centered care: “providing care that is ...
(Date:10/22/2014)... 22, 2014 With the Affordable Care Act ... by the American Institutes for Research (AIR) finds that three ... use health insurance, but 42 percent say they are not ... before signing up for coverage. , The AIR survey found ... percent able to calculate correctly how much they owe for ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the most ... recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the ... the world. , “iPower is one of the most ... various kinds of useful products for new and old ... customer service and a number of features which will ...
(Date:10/22/2014)... Weight Your Body’s Way , In a world where a ... certainly can be difficult to choose the right weight loss ... doing it the healthy way? Set aside the fads and ... exercise regularly, and choose foods with the most nutritional benefits. ... to exercise more and eat less. Despite the number of ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, ... Sales, will be speaking on the subject of “Event ... October 28, at the Holiday Inn in New York ... well as a Tech Demo at 12:45pm, to educate ... more engaging event experience. , The Annual Meetings Technology ...
Breaking Medicine News(10 mins):Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2
... 5-Year Contract Makes AccuVein,s Device Now Available to Veteran ... N.Y., June 29 AccuVein LLC today announced a ... This agreement brings the AccuVein AV300, the world,s first ... military and veteran hospitals. , , The AccuVein ...
... CryoLife, Inc., (NYSE: CRY ) an implantable ... announced that, according to company data, CryoLife,s BioGlue(R) Surgical ... procedures throughout the world since its introduction into the ... in 2001. BioGlue is a leading surgical adhesive ...
... step closer to preventing kidney stones, osteoporosis , MONDAY, ... contributes to both kidney stones and osteoporosis has been ... promising target for new drugs to better regulate calcium ... gene encoding claudin 14 (CLDN14), a protein expressed in ...
... risky behavior and pessimistic outlook surprises experts, , MONDAY, ... risky behavior reflects a youthful sense of immortality, a ... teens believe they will die before age 35 -- ... research has shown that typically teenagers are no worse ...
... Bayer/Onyx and Boehringer Ingelheim, and Increased Use of Existing ... According to a New Report from Decision Resources , ... one of the world,s leading research and advisory firms ... of targeted agents as well as increased use of ...
... , - 51 Elsevier Journals Receive ... Elsevier, the leading publisher of scientific, technical and ... impact factor performance in 2008. Elsevier overall saw 75% of ... to the 2008,Journal Citation Report(R) published by ThomsonReuters, Elsevier journals,took ...
Cached Medicine News:Health News:AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule 2Health News:AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule 3Health News:BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates 2Health News:BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates 3Health News:BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates 4Health News:Discovery Points to Regulation of Calcium Metabolism 2Health News:15 Percent of U.S. Teens Think They'll Die Young 2Health News:15 Percent of U.S. Teens Think They'll Die Young 3Health News:Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018 2Health News:Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018 3Health News:Elsevier Announces 2008 Journal Impact Factor Highlights 2Health News:Elsevier Announces 2008 Journal Impact Factor Highlights 3
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
Used for pediatric urethral dilation. The dilators have a closed, rounded, 20 angled tip. Supplied sterile in peel-open packages. Intended for one-time use....
... stone manipulation and removal ... Enhanced wire strength permits ... the ureter. The Unidex ... one-handed operation. Supplied sterile ...
... Used for soft-tissue ... limited to paravaginal repairs, ... or rectocele. Surgisis® ES ... enhanced strength for intraoperative ...
Medicine Products: